6-bromo-8-fluoro-1,4-dihydroquinazolin-4-one, 98%, 500mg

4-Trifluoromethyl-5,6,7,8-tetrahydroquinazolin-2-ylamine, 95.0%, 10g

Boc-Met-OSu, 95.0%, 100g

4-methyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione, 95.0%, 5g

2-Decenoic acid, 10-hydroxy-, (2E)-, 95%, 10g

2-hydroxy-3-(3-methoxyphenyl)prop-2-enoic acid, 95%, 2.5g

1-cloroadamantano, mínimo 98 %, para síntesis, 25 g, envase de vidrio

Matraces aforados ROTILABO® con cuello graduado, 50 ml, 1 pieza

3-Fluoro-5-((7-(methylthio)-1-oxo-2,3-dihydro-1H-inden-4-yl)oxy)benzonitrile, 98%, 50mg

5,7-Dimethyl[1,8]naphthyridin-2-amine, 95%, 250mg

(4-(2-Phenyl-1H-benzo[d]imidazol-1-yl)phenyl)boronic acid, 95.0%, 25g

4-Bromo-2-(difluoromethoxy)-1-fluorobenzene, 95.0%, 10g

2-Methyl-8-(pyridin-2-yl)benzofuro[2,3-b]pyridine, 98.0%, 1g